Veeva Systems (VEEV) Stock Price

Veeva Systems Price

NYSE·CLOSED
230.47USD+12.67 (+5.65 %)
Market closed

Revenue has compounded at 40.9% per year over the past 16 years to 3.20 B USD. Earnings per share have grown at 43.5% per year over the last 14 years. Veeva Systems's net margin stands at 28.4%, up from 23.1% several years earlier. Analysts set a median price target of 326.40 USD, implying 41.6% above the current price. Of 39 analysts, 28 rate the stock a buy — an overall Buy consensus. The stock trades about 52% above its 52-week low.

Veeva Systems stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Veeva Systems over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Veeva Systems stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Veeva Systems's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Veeva Systems Stock Price History
DateVeeva Systems Price
8/7/2026230.47 USD
8/6/2026217.80 USD
8/5/2026212.35 USD
8/4/2026210.41 USD
8/3/2026206.25 USD
7/31/2026203.78 USD
7/30/2026201.56 USD
7/29/2026208.55 USD
7/27/2026195.30 USD
7/23/2026179.58 USD
7/22/2026184.55 USD
7/21/2026189.24 USD
7/20/2026197.41 USD
7/17/2026195.38 USD
7/16/2026197.37 USD
7/15/2026193.67 USD
7/14/2026193.09 USD
7/13/2026198.18 USD
7/10/2026190.12 USD
7/9/2026189.70 USD
7/8/2026191.11 USD
7/7/2026192.30 USD
7/6/2026190.15 USD
7/2/2026192.74 USD
7/1/2026184.22 USD
6/30/2026177.47 USD
6/29/2026173.89 USD
6/26/2026171.36 USD
6/25/2026158.08 USD
6/24/2026161.35 USD
6/23/2026159.71 USD
6/22/2026152.05 USD
6/18/2026153.31 USD
6/17/2026160.23 USD
6/16/2026160.05 USD
6/15/2026164.20 USD
6/12/2026158.46 USD
6/11/2026161.49 USD
6/10/2026166.65 USD
6/9/2026167.68 USD
6/8/2026167.24 USD
6/5/2026173.89 USD
6/4/2026179.38 USD
6/3/2026175.31 USD
6/2/2026179.95 USD
6/1/2026189.26 USD
5/29/2026171.12 USD
5/28/2026163.72 USD
5/27/2026161.69 USD
5/26/2026158.68 USD
5/22/2026159.29 USD
5/21/2026160.93 USD
5/20/2026161.72 USD
5/19/2026163.31 USD
5/18/2026163.85 USD
5/15/2026158.86 USD
5/14/2026156.25 USD
5/13/2026155.73 USD
5/12/2026159.42 USD
5/11/2026159.33 USD
5/8/2026166.34 USD
5/7/2026168.25 USD
5/6/2026167.35 USD
5/5/2026171.19 USD
5/4/2026170.22 USD
5/1/2026171.60 USD
4/30/2026155.97 USD
4/29/2026158.22 USD
4/28/2026158.49 USD
4/27/2026160.45 USD
4/24/2026161.13 USD
4/22/2026163.78 USD
4/21/2026167.79 USD
4/20/2026168.84 USD
4/17/2026167.95 USD
4/16/2026167.69 USD
4/15/2026167.30 USD
4/14/2026159.09 USD
4/13/2026158.45 USD
4/10/2026151.43 USD
4/9/2026157.08 USD
4/8/2026166.57 USD
4/7/2026172.52 USD
4/6/2026174.64 USD
4/2/2026173.98 USD
4/1/2026172.74 USD
3/31/2026175.66 USD
3/30/2026175.96 USD
3/27/2026172.59 USD
3/26/2026178.28 USD
3/25/2026178.11 USD
3/24/2026179.11 USD
3/23/2026185.23 USD
3/20/2026184.07 USD
3/19/2026185.59 USD
3/18/2026184.03 USD
3/17/2026186.70 USD
3/16/2026185.28 USD
3/13/2026178.88 USD
3/12/2026180.79 USD
3/11/2026187.09 USD
3/10/2026189.69 USD
3/9/2026195.57 USD
3/6/2026195.49 USD
3/5/2026196.06 USD
3/4/2026188.48 USD
3/3/2026185.91 USD
3/2/2026181.45 USD
2/27/2026182.01 USD
2/26/2026182.86 USD
2/25/2026176.46 USD
2/24/2026175.79 USD
2/23/2026172.17 USD
2/20/2026180.31 USD
2/19/2026182.57 USD
2/18/2026181.25 USD
2/17/2026176.82 USD
2/13/2026174.11 USD
2/12/2026171.99 USD
2/11/2026177.04 USD
2/10/2026186.99 USD
2/9/2026184.61 USD
2/6/2026183.65 USD
2/5/2026183.85 USD
2/4/2026190.69 USD
2/3/2026190.80 USD
2/2/2026203.35 USD
1/30/2026203.92 USD
1/29/2026209.98 USD
1/28/2026217.99 USD
1/27/2026217.87 USD
1/26/2026224.18 USD
1/23/2026222.00 USD
1/22/2026225.28 USD
1/21/2026219.73 USD
1/20/2026216.26 USD
1/16/2026222.21 USD
1/15/2026218.95 USD
1/14/2026218.86 USD
1/13/2026228.49 USD
1/12/2026233.21 USD
1/9/2026240.12 USD
1/8/2026241.16 USD
1/7/2026239.35 USD
1/6/2026237.87 USD
1/5/2026221.32 USD
1/2/2026219.49 USD
12/31/2025223.23 USD
12/30/2025224.64 USD
12/29/2025225.02 USD
12/26/2025224.65 USD
12/24/2025223.15 USD
12/23/2025224.26 USD
12/22/2025223.36 USD
12/19/2025221.86 USD
12/18/2025218.10 USD
12/17/2025215.46 USD
12/16/2025219.30 USD
12/15/2025220.10 USD
12/12/2025223.26 USD
12/11/2025229.49 USD
12/10/2025229.16 USD
12/9/2025232.00 USD
12/8/2025239.05 USD
12/5/2025242.00 USD
12/4/2025242.28 USD
12/3/2025241.33 USD
12/2/2025240.14 USD
12/1/2025240.41 USD
11/28/2025240.29 USD
11/26/2025240.67 USD
11/25/2025239.95 USD
11/24/2025235.74 USD
11/21/2025244.06 USD
11/20/2025270.50 USD
11/19/2025273.00 USD
11/18/2025273.72 USD
11/17/2025277.01 USD
11/14/2025293.36 USD
11/13/2025291.70 USD
11/12/2025296.96 USD
11/11/2025299.10 USD
11/10/2025295.75 USD
11/7/2025294.86 USD
11/6/2025291.21 USD
11/5/2025295.26 USD
11/4/2025293.49 USD
11/3/2025292.72 USD
10/31/2025291.20 USD
10/30/2025285.03 USD
10/29/2025286.67 USD
10/28/2025291.35 USD
10/27/2025295.69 USD
10/24/2025293.02 USD
10/23/2025291.50 USD
10/22/2025289.94 USD
10/21/2025289.84 USD
10/20/2025285.91 USD
10/17/2025283.73 USD
10/16/2025292.73 USD
10/15/2025287.38 USD
10/14/2025287.65 USD
10/13/2025286.09 USD
10/10/2025286.59 USD
10/9/2025298.47 USD
10/8/2025301.80 USD
10/7/2025306.22 USD
10/6/2025299.76 USD
10/3/2025296.28 USD
10/2/2025300.79 USD
10/1/2025293.26 USD
9/30/2025297.91 USD
9/29/2025293.00 USD
9/26/2025290.27 USD
9/25/2025279.93 USD
9/24/2025277.94 USD
9/23/2025278.84 USD
9/22/2025281.12 USD
9/19/2025277.79 USD
9/18/2025279.08 USD
9/17/2025274.58 USD
9/16/2025273.88 USD
9/15/2025276.27 USD
9/12/2025276.43 USD
9/11/2025279.47 USD
9/10/2025274.60 USD
9/9/2025282.68 USD
9/8/2025282.78 USD
9/5/2025272.93 USD
9/4/2025270.06 USD
9/3/2025270.95 USD
9/2/2025269.98 USD
8/29/2025269.20 USD
8/28/2025272.33 USD
8/27/2025293.59 USD
8/26/2025286.54 USD
8/25/2025285.18 USD
8/22/2025290.86 USD
8/21/2025282.28 USD
8/20/2025284.02 USD
8/19/2025284.35 USD
8/18/2025282.10 USD
8/15/2025280.61 USD
8/14/2025274.98 USD
8/13/2025279.18 USD
8/12/2025275.43 USD
8/11/2025276.96 USD
Access this data via the Eulerpool API
Get Free API Key

Veeva Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2024
2.36 B USD
429.33 M USD
525.71 M USD
Jan 1, 2025
2.75 B USD
691.44 M USD
714.14 M USD
Jan 1, 2026
3.20 B USD
916.37 M USD
908.91 M USD
Jan 1, 2027 (e)
3.65 B USD
1.07 B USD
1.49 B USD
Jan 1, 2028 (e)
4.09 B USD
1.20 B USD
1.65 B USD
Jan 1, 2029 (e)
4.59 B USD
1.35 B USD
1.86 B USD
Jan 1, 2030 (e)
5.08 B USD
1.49 B USD
2.09 B USD
Jan 1, 2031 (e)
5.70 B USD
1.68 B USD
2.38 B USD

Veeva Systems Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 7:40 AM
 
REVENUEB USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB USD
EBITB USD
EBIT MARGIN%
NET INCOMEB USD
NET INCOME GROWTH%
SHARESM
201620172018201920202021202220232024202520262027e2028e2029e2030e2031e
0.410.540.690.861.101.471.852.162.362.753.203.654.094.595.085.70
30.6733.0126.8424.9328.0732.7026.2816.499.6516.2116.3514.1212.0412.4410.5612.27
65.2868.0169.4271.4672.4672.0872.8171.6971.3574.5175.5275.5275.5275.5275.5275.52
0.270.370.480.620.801.061.351.551.692.052.412.753.093.473.844.31
0.080.120.160.220.290.380.510.460.430.690.921.071.201.351.491.68
19.0722.0622.7525.7525.9125.7327.3021.3018.1525.1628.6729.4029.4029.3929.4029.40
0.050.080.150.230.300.380.430.490.530.710.911.491.651.862.092.38
35.0042.5996.1051.6631.4425.9112.6614.057.8036.0027.1763.9910.6813.0512.0214.09
147.44154.26156.03158.75161.71163.03162.30163.76164.98167.95165.99165.99165.99165.99165.99165.99
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Veeva Systems generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Veeva Systems retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Veeva Systems's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Veeva Systems has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Veeva Systems's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Veeva Systems stock margins

The Veeva Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Veeva Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Veeva Systems.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
72.79 %
27.31 %
23.09 %
Jan 1, 2023
71.72 %
21.30 %
22.63 %
Jan 1, 2024
71.35 %
18.16 %
22.24 %
Jan 1, 2025
74.53 %
25.17 %
26.00 %
Jan 1, 2026
75.53 %
28.68 %
28.44 %
Jan 1, 2027 (e)
75.53 %
29.41 %
40.85 %
Jan 1, 2028 (e)
75.53 %
29.41 %
40.36 %
Jan 1, 2029 (e)
75.53 %
29.41 %
40.56 %

Veeva Systems Stock Revenue, EBIT, Earnings per Share

The Veeva Systems earnings per share therefore indicates how much revenue Veeva Systems has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2022
11.40 USD
3.11 USD
2.63 USD
Jan 1, 2023
13.16 USD
2.80 USD
2.98 USD
Jan 1, 2024
14.33 USD
2.60 USD
3.19 USD
Jan 1, 2025
16.35 USD
4.12 USD
4.25 USD
Jan 1, 2026
19.25 USD
5.52 USD
5.48 USD
Jan 1, 2027 (e)
22.18 USD
6.46 USD
9.06 USD
Jan 1, 2028 (e)
24.85 USD
7.24 USD
10.03 USD
Jan 1, 2029 (e)
27.94 USD
8.14 USD
11.33 USD

Veeva Systems business model & stock analysis

The history of Veeva Systems Inc: Veeva Systems is a leading company in the field of cloud software for the life science industry. The company was founded in 2007 and is headquartered in Pleasanton, California. Veeva was created by Peter Gassner and Matt Wallach to improve the management of clinical trials and collaboration in the pharmaceutical industry. Business model of Veeva Systems Inc: The business model of Veeva Systems is focused on improving efficiency and collaboration in the life science industry. The company offers cloud-based software solutions tailored to the needs of life science companies. These solutions include CRM systems, clinical trial management software, data management tools, and analytics tools. Veeva Systems was founded as a CRM company for the life science industry. With its first software, Veeva CRM, the company revolutionized how pharmaceutical companies manage and collaborate with their sales forces. Since then, Veeva Systems has expanded its portfolio and offers a wide range of software solutions, ranging from planning and conducting clinical trials to collecting and analyzing data. Divisions of Veeva Systems Inc: Veeva Systems is divided into three divisions: 1) Commercial Cloud: This division of Veeva Systems provides software solutions for managing customer relationships, sales and marketing activities, and digital marketing for life science companies. 2) Vault: The Vault division of Veeva Systems offers software solutions for managing content, data, and processes involved in clinical trials and other research projects. 3) Data Cloud: This division offers analytics and data management tools that enable life science companies to collect, manage, and analyze their data. Products of Veeva Systems Inc: Veeva CRM: A CRM software solution that allows pharmaceutical companies to control and manage their sales and marketing activities. Veeva Vault: A suite of software solutions that facilitate the management of clinical trials and research projects. Vault provides solutions for electronic data capture, electronic informed consent forms (eICFs), clinical data management, and document management. Veeva Network: A cloud-based platform that enables life science companies to simultaneously collect patient data and advertise for it. Veeva OpenData: A database of contacts and companies from the life science industry that is regularly updated. Veeva Align: A tool for optimizing personnel deployment and ensuring compliance in the sales of life science companies. Veeva Vault QualityOne: A platform for managing quality control processes, including supply chain monitoring, compliance with regulations, and ensuring standards. Conclusion: Veeva Systems has positioned itself as a leading provider of cloud software solutions for the life science industry and offers its portfolio of CRM, clinical trial management, data management, and analytics tools. The company has succeeded in improving collaboration in the pharmaceutical industry by leveraging cloud technologies to increase effectiveness, safety, and compliance.

Veeva Systems Employees

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Veeva Systems Employees
Details
Date
Veeva Systems Employees
Jan 1, 2019
- Employees
Jan 1, 2020
- Employees
Jan 1, 2021
- Employees
Jan 1, 2022
- Employees
Jan 1, 2023
- Employees
Jan 1, 2024
- Employees
Jan 1, 2025
- Employees
Jan 1, 2026
- Employees

Veeva Systems Segments

Veeva Systems Revenue by Segment (1/4)

  • Max

Subscription
Professional services and other
Details
Date
Subscription
Subscription services
Professional services and other
Jan 1, 2026
2.68 B USD
0.00 USD
511.12 M USD

Veeva Systems Revenue by Segment (2/4)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Subscription services
Total subscription services
Professional services and other
Total professional services
Jan 1, 2026
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Veeva Systems Revenue by Segment (3/4)

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Details
Date
Subscription services, veeva commercial cloud
Subscription services, veeva vault
Veeva Vault
Veeva Commercial Cloud
Professional services, veeva vault
Professional services, veeva commercial cloud
Jan 1, 2026
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Veeva Systems Revenue by Segment (4/4)

  • Max

Reportable Segment
Details
Date
Reportable Segment
Jan 1, 2026
3.20 B USD

Veeva Systems Revenue by Region

  • 3 Years

  • 5 Years

  • Max

North America
Europe
Asia Pacific
Europe and other
Other international
Middle East, Africa, and Latin America
Details
Date
North America
Europe
Asia Pacific
Europe and other
Other international
Middle East, Africa, and Latin America
Jan 1, 2017
297.01 M USD
0.00 USD
86.36 M USD
160.67 M USD
0.00 USD
0.00 USD
Jan 1, 2018
376.54 M USD
0.00 USD
106.62 M USD
202.41 M USD
0.00 USD
0.00 USD
Jan 1, 2021
838.19 M USD
400.79 M USD
183.85 M USD
0.00 USD
0.00 USD
42.24 M USD
Jan 1, 2022
1.06 B USD
509.13 M USD
225.97 M USD
0.00 USD
0.00 USD
51.91 M USD
Jan 1, 2023
1.25 B USD
598.83 M USD
244.66 M USD
0.00 USD
0.00 USD
57.82 M USD
Jan 1, 2024
1.39 B USD
662.56 M USD
250.60 M USD
0.00 USD
0.00 USD
63.09 M USD
Jan 1, 2025
1.62 B USD
790.78 M USD
265.74 M USD
0.00 USD
0.00 USD
68.41 M USD
Jan 1, 2026
1.90 B USD
939.63 M USD
280.16 M USD
0.00 USD
72.18 M USD
0.00 USD

Veeva Systems Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Veeva Systems historical P/E ratio, EBIT multiple, and P/S ratio

Veeva Systems annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Veeva Systems shares outstanding

The number of shares of Veeva Systems was 167.95 M in 2025. This indicates how many shares Veeva Systems is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2022
162.30 M Stocks
Jan 1, 2023
163.76 M Stocks
Jan 1, 2024
164.98 M Stocks
Jan 1, 2025
167.95 M Stocks
Jan 1, 2026
165.99 M Stocks
Jan 1, 2027 (e)
165.99 M Stocks
Jan 1, 2028 (e)
165.99 M Stocks
Jan 1, 2029 (e)
165.99 M Stocks

Current Veeva Systems forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
71.79 % (28)
Hold
23.08 % (9)
Sell
5.13 % (2)
12M Price Target
326.40
Last Price
230.47
Currency
USD
12M Return Potential
41.62 %
LTM Return
0 %

Veeva Systems Analyst Rating Actions

DateFirmActionRatingReliability
6/4/2026
Wells Fargo
Wells Fargo
MaintainedOverweight56
6/4/2026
UBS
UBS
MaintainedNeutral51
6/4/2026
Stifel
Stifel
MaintainedBuy–
6/4/2026
RBC Capital
RBC Capital
MaintainedOutperform52
6/4/2026
Piper Sandler
Piper Sandler
MaintainedOverweight51
6/4/2026
Oppenheimer
Oppenheimer
MaintainedOutperform65
6/4/2026
Needham
Needham
MaintainedBuy70
6/4/2026
Mizuho
Mizuho
MaintainedOutperform31
6/4/2026
Goldman Sachs
Goldman Sachs
MaintainedSell–
6/4/2026
Evercore ISI Group
Evercore ISI Group
MaintainedIn Line62

Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.

Veeva Systems Earnings Calls

2025

Veeva Systems Earnings Estimates & Surprises

DateEPS estimateEPS ActualRevenue EstimatePrice reactionQuarterly report
8/26/20262.27USD-923.41 MUSD-2027 Q2
6/3/20262.17USD-870.72 MUSD-2027 Q1
3/4/20261.97USD-826.83 MUSD-2026 Q4
11/20/20251.99USD-808.67 MUSD-2026 Q3
12/5/20241.61USD-698.61 MUSD-2025 Q3
5/29/20241.30USD-658.40 MUSD-2025 Q1
2/28/20241.30USD-635.72 MUSD-2024 Q4
11/29/20231.22USD-635.01 MUSD-2024 Q3
8/29/20231.16USD-618.96 MUSD-2024 Q2
5/30/20231.10USD-585.69 MUSD-2024 Q1

EESG©

Eulerpool ESG Scorecard© for the Veeva Systems stock

51/100
36
Environment
63
Social
53
Governance
E

Environment

20
Scope 1 - Direct Emissions264
Scope 2 - Indirect emissions from purchased energy280
Scope 3 - Indirect emissions within the value chain49,237
Total CO₂ emissions544
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees44
Percentage of women in management—
Percentage of Asian employees30
Share of Asian management25
Percentage of Hispanic/Latino employees6
Hispano/Latino Management share5.1
Percentage of Black employees3.3
Black Management Share1.3
Percentage of white employees57.4
White Management Share66
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Veeva Systems shareholder structure

% Name
7.03180%
BLACKROCK, INC.
BLACKROCK, INC.
4.48718%
VANGUARD PORTFOLIO MANAGEMENT LLC
VANGUARD PORTFOLIO MANAGEMENT LLC
4.05786%
VANGUARD CAPITAL MANAGEMENT LLC
VANGUARD CAPITAL MANAGEMENT LLC
3.81500%
ALLIANCEBERNSTEIN L.P.
ALLIANCEBERNSTEIN L.P.
2.99588%
LINONIA PARTNERSHIP LP
LINONIA PARTNERSHIP LP
2.51949%
PRINCIPAL FINANCIAL GROUP INC
PRINCIPAL FINANCIAL GROUP INC
...

Veeva Systems Beneficial Ownership Filings (SEC 13D/G)

Free Float
91.7%
Float Shares
-
Shares Outstanding
-
StakeHolderFiling
11.20%
Peter P. Gassner
Peter P. Gassner
SEC ↗
10.65%
Wellington Management Group LLP
Wellington Management Group LLP
SEC ↗
10.40%
2
2
SEC ↗
10.20%
52-0556948
52-0556948
SEC ↗
9.18%
The Vanguard Group - 23-1945930
The Vanguard Group - 23-1945930
SEC ↗
6.70%
Morgan Stanley Investment Management Inc.
Morgan Stanley Investment Management Inc.
SEC ↗
6.40%
(1) BlackRock, Inc.
(1) BlackRock, Inc.
SEC ↗
6.30%
6.3% (2)(3)(4)
6.3% (2)(3)(4)
SEC ↗
5.82%
Brown Capital Management, LLC
Brown Capital Management, LLC
SEC ↗
5.40%
Artisan Partners Limited Partnership
Artisan Partners Limited Partnership
SEC ↗

Veeva Systems Executives and Management Board

14 members · avg. age 58 · 21 % women

PG

Mr. Peter Gassner (60)

Chief Executive Officer, Director · since 2007

172.44 M USD

Management

TS

Mr. Thomas Schwenger (57)

President, Chief Customer Officer

5.17 M USD
BW

Mr. Brian Van Wagener (43)

Chief Financial Officer

3.89 M USD
EZ

Ms. E. Nitsa Zuppas (55)

President, Chief of Staff

3.72 M USD
JF

Mr. Jonathan Faddis (52)

Senior Vice President, General Counsel, Secretary

3.22 M USD
GH

Mr. Gunnar Hansen

Investor Contact · since 2023

–

Board of Directors

GR

Mr. Gordon Ritter (60)

Independent Chairman of the Board

335,090.00 USD
MM

Mr. Marshall Mohr (69)

Independent Director

325,081.00 USD
MC

Mr. Mark Carges (63)

Independent Director

305,062.00 USD
MH

Dr. Mary Hedley (62)

Independent Director

295,053.00 USD
PH

Ms. Priscilla Hung (58)

Independent Director

295,053.00 USD
PS

Mr. Paul Sekhri (67)

Independent Director

285,043.00 USD

Frequently asked questions about Veeva Systems

Veeva Systems Inc is a leading cloud-based software company that focuses on providing solutions specifically for the life sciences industry. Their business model revolves around offering industry-specific applications such as customer relationship management (CRM), content management, and data insights for pharmaceutical and biotechnology companies. Veeva Systems Inc enables these organizations to streamline their processes, improve collaboration, and maximize productivity by leveraging their cloud-based platform. With an emphasis on driving innovation and maintaining regulatory compliance, Veeva Systems Inc aims to empower life sciences companies to deliver better products, enhance customer engagement, and drive overall growth within the industry.

Veeva Systems Inc is primarily active in the pharmaceutical and life sciences industries.

The main competitors of Veeva Systems Inc in the market are Salesforce.com, Inc. and Oracle Corporation.

Veeva Systems Inc is a leading provider of cloud-based software solutions for the life sciences industry. Founded in 2007 by Peter Gassner and Matt Wallach, Veeva Systems has a rich history of innovation and growth. The company initially focused on developing customer relationship management (CRM) solutions specifically tailored for pharmaceutical and biotechnology companies. Today, Veeva Systems offers a comprehensive suite of products that empower life sciences organizations to streamline their operations, enhance collaboration, and improve regulatory compliance. With a customer-centric approach and a commitment to delivering industry-specific solutions, Veeva Systems has established itself as a trusted partner in the life sciences sector.

Veeva Systems Inc has achieved several significant milestones since its inception. One of the major accomplishments includes becoming the leading provider of cloud-based software solutions for the life sciences industry. The company has consistently delivered innovative technology, empowering organizations to streamline their operations, improve efficiency, and enhance customer relationships. Veeva Systems Inc has also expanded its global presence by establishing offices in key regions worldwide, building a strong customer base, and forming strategic partnerships with industry leaders. Additionally, the company has received recognition for its commitment to customer success, product innovation, and overall industry impact.

Veeva Systems Inc is primarily present in various countries and regions around the world. As a leading provider of cloud-based software for the life sciences industry, Veeva Systems Inc has an extensive global presence. The company operates in North America, including the United States and Canada, where it is headquartered. Veeva Systems Inc also has a strong presence in Europe, with operations in countries such as the United Kingdom, Germany, France, and Switzerland. Additionally, the company serves clients in the Asia-Pacific region, including countries like Japan, China, and Australia. With its widespread presence, Veeva Systems Inc continues to expand its reach to better serve its customers globally.

Veeva Systems Inc represents a strong commitment to customer success and innovation. The company's corporate philosophy revolves around empowering life sciences and other regulated industries with cloud-based software solutions. Veeva Systems values collaboration, integrity, and excellence in delivering their specialized products and services. With a focus on industry-specific solutions, Veeva Systems aims to streamline processes, improve efficiency, and ensure compliance within highly regulated sectors. Veeva Systems Inc strives to be a trusted partner, offering tailored solutions and continuous support to drive success for their customers in the ever-evolving market.

Analysts currently set an average price target of 313.73 USD for the Veeva Systems stock (median: 326.40 USD), implying +36.1 % versus the latest price. The consensus is based on 39 analyst ratings.

Veeva Systems Analyst Price Targets 2026

39 analysts currently rate the Veeva Systems stock: 28 recommend buying, 9 holding and 2 selling.

Veeva Systems Analyst Price Targets 2026

Converted at the current exchange rate, the Veeva Systems share trades at 199.47 EUR (230.47 USD).

The Veeva Systems share (VEEV) is listed on 8 stock exchanges, including: NYSE (VEEV), XETRA (VEE.DE), Frankfurt (VEE.F), München (VEE.MU), Düsseldorf (VEE.DU), London (0LO3.L), London (0LO3.L), SIX (Zürich) (VEE.SW).

Veeva Systems Inc is a US software company specializing in solutions for the life science industry. The company was founded in 2007 by Peter Gassner and is headquartered in Pleasanton, California. Veeva Systems' business model is based on the development and distribution of cloud-based software solutions for the pharmaceutical, biotechnology, and medical device industries. The products are divided into various divisions, including Veeva CRM, Vault, and Network. The Veeva CRM division offers a cloud-based customer relationship management solution tailored to the needs of the life science industry. This solution allows companies to track and manage all interactions with their customers, from doctors and clinics to medical professionals. The solution also provides a range of tools to measure the effectiveness of marketing and sales activities. Veeva Systems' Vault division is a platform for connecting companies operating in the life science industry. Vault solutions cover topics such as document management, inventory management, and quality assurance. The Vault solutions help companies manage and optimize all aspects of their business cycle, from product development to regulatory compliance. Veeva Systems' Network division provides a platform for collaboration and interaction between pharmaceutical companies, medical professionals, and patients. Network solutions include a digital marketing platform, an online community for medical professionals, and a patient engagement solution. Veeva Systems' business model is based on a subscription model, where customers pay for the use of Veeva Systems' software and services. The company earns money in this way and is able to serve its customers and improve its products. Veeva Systems has experienced steady growth in recent years and is now a leading provider of software solutions for the life science industry. The company has over 975 customers in over 165 countries and is a preferred partner for the world's largest pharmaceutical companies. Overall, Veeva Systems' business model offers customers in the life science industry a wide range of products and services to optimize their business processes, accelerate product development, and improve regulatory compliance.

The revenue of Veeva Systems is 3.20 B USD. This figure is based on current financial data and reflects the company's business performance.

The profit of Veeva Systems is 908.91 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Veeva Systems is currently 42.09. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Veeva Systems stock.

The price-to-sales ratio (P/S) of Veeva Systems is currently 11.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Veeva Systems stock.

The Eulerpool Quality Score for Veeva Systems is 8/10.

The ISIN of Veeva Systems is US9224751084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Veeva Systems is A1W5SA. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Veeva Systems is VEEV. The ticker symbol is used to trade Veeva Systems shares on the stock exchange.

Veeva Systems paid dividends every year for the past 0 years.

Veeva Systems is assigned to the 'Health' sector.

The dividends of Veeva Systems are distributed in USD.

All fundamentals and in-depth analysis of Veeva Systems

Our stock analysis for Veeva Systems stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veeva Systems. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Veeva Systems Stock
Veeva Systems Revenue→
Veeva Systems Stock
Veeva Systems Net Income→
Veeva Systems Stock
Veeva Systems P/E→
Veeva Systems Stock
Veeva Systems P/S→
Veeva Systems Stock
Veeva Systems EBIT→
Veeva Systems Stock
Veeva Systems Dividend→
Veeva Systems Stock
Veeva Systems Directors Dealings→
Veeva Systems Stock
Veeva Systems Stocks→
Veeva Systems Stock
Veeva Systems Market capitalization→
Veeva Systems Stock
Veeva Systems Debt→
Veeva Systems Stock
Veeva Systems Liabilities→
Veeva Systems Stock
Veeva Systems Equity→
Veeva Systems Stock
Veeva Systems AAQS→
Veeva Systems Stock
Veeva Systems Employees→
Veeva Systems Stock
Veeva Systems ROE→
Veeva Systems Stock
Veeva Systems ROA→
Veeva Systems Stock
Veeva Systems ROCE→
Veeva Systems Stock
Veeva Systems News→
Veeva Systems Stock
Veeva Systems Analyst Price Targets→

Health Stocks

VentriPoint DiagnosticsVeerhealth CareVenus Medtech HangzhouVectus BiosystemsVenus RemediesVectorite BiomedicalVera TherapeuticsVcanbio Cell & Gene Engineering CorpVeracyteVaxxinityVeradigmVaxil BioAll Stocks A–Z →